When was Toolbox Genomics founded?

Toolbox Genomics was founded in 2016 and raised its 1st funding round 1 year after it was founded.

Where is Toolbox Genomics located?

Toolbox Genomics is headquartered in San Francisco, United States.

Who is the current CEO of Toolbox Genomics?

Didier Perez of Toolbox Genomics.

How many employees does Toolbox Genomics have?

As of May 31, 2026, the latest employee count at Toolbox Genomics is 2.

Is Toolbox Genomics a funded company?

Toolbox Genomics is a funded company, having raised a total of $***** in its 1st and only funding round, a Seed round on Jan 11, 2017.

When was the latest funding round of Toolbox Genomics?

Toolbox Genomics' latest funding was a $***** Seed round on Jan 11, 2017, with participation from 0 investor. Its primary sector is Genomics. In United States, the Genomics sector has seen $1.3B in funding in 2026 to date.

Where does Toolbox Genomics rank among its competitors?

Toolbox Genomics ranks 173rd amongst 247 active competitors, of which 74 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Adela, which secured $5M in Apr, 2026.

Who are the top competitors of Toolbox Genomics?

Toolbox Genomics' top competitors include Helix, Caris Life Sciences and Geneoscopy. Among them, Adela secured the most recent funding round in April, 2026.

Toolbox Genomics - 2026 Company Profile, Team, Funding & Competitors

Company Details

Provider of genome-based health insights to consumers. The company enables users to upload their genomic data on their platform and based on that data the company provides practical and actionable food and lifestyle recommendations using PubMed publications that point to links between genetic biomarkers, and food, fitness, and lifestyle interventions. Currently, the company is considering 60 biomarkers with an average of about 15 recommendations and will charge $49 per time used.

Website: www.toolboxgenomics.com/
Social
Email ID: *****@toolboxgenomics.com
Phone Number: +1 **********

Key Metrics

Founded Year

2016

Location

San Francisco, United States

Stage

Seed

Latest Funding Round

Seed, Jan 11, 2017, $*****

Ranked

173^rd among 247 active competitors

Employee Count

2 as on May 31, 2026

Similar Companies

MyHeritage & 673 more

View Toolbox Genomics' full profile

Toolbox Genomics has raised funding over 1 round.

Here is the list of recent funding rounds of Toolbox Genomics:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jan 11, 2017	3122230	Seed	2784828	6410334	8821100	9563091

Access funding benchmarks and valuations. Sign up today!

View details of Toolbox Genomics's funding rounds and investors

The founders of Toolbox Genomics is Elvina Hewitt.

Here are the details of Toolbox Genomics' key team members:

Elvina Hewitt: Co-Founder of Toolbox Genomics.
Didier Perez: Former Co-Founder of Toolbox Genomics.
Contact Info: 1 email address

View details of Toolbox Genomics's Founder profiles and Board Members

Toolbox Genomics' employee count trend

Toolbox Genomics has 2 employees as of May 26. Here is Toolbox Genomics's employee count trend over the years:

Employee count trend for Toolbox Genomics

Uncover Toolbox Genomics' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Toolbox Genomics include Helix, Caris Life Sciences and Geneoscopy. Here is the list of Top 10 competitors of Toolbox Genomics, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Helix 2015, San Francisco (United States), Series E	Provider of a genomic database for clinical research	$435M	DFJ Growth, Kleiner Perkins & 12 others	71/100
2nd	Caris Life Sciences 1996, Irving (United States), Public	Developer of panomic disease profiling technologies for cancer precision medicine	$1.23B	Sixth Street, Braidwell & 19 others	70/100
3rd	Geneoscopy 2015, St. Louis (United States), Series C	Developer of non-invasive biomarker tests for colorectal cancer	$219M	LightChain Capital, Cultivation Capital & 18 others	67/100
4th	Intellia Therapeutics 2014, Cambridge (United States), Public	Developer of therapeutics based on CRISPR/Cas9 technology for multiple diseases	$85M	Atlas Venture, Orbimed & 10 others	66/100
5th	Precipio Diagnostics 1997, New Haven (United States), Public	Provider of cancer diagnostics and second opinion tools	$800K	Enhanced Capital, Connecticut Innovations ... & 3 others	63/100
6th	Adela 2021, San Francisco (United States), Series A	Developer of a platform for detection of cancer	$139M	F-Prime Capital, LabCorp & 5 others	62/100
7th	UniQure 1998, Amsterdam (Netherlands), Public	Developer of gene-based therapies for patients with genetic or acquired diseases	$111M	Gilde Healthcare, Foresite Capital & 11 others	62/100
8th	Exicure 2009, Skokie (United States), Public	developer of gene silencing & immunomodulatory drugs using spherical nucleic acid (SNA) technology	$72.3M	Abbott Biotech Ventures, Luye Pharma & 18 others	61/100
9th	GenSight Biologics 2011, Paris (France), Public	Developer of viral vector-based gene therapies for retinal neurodegenerative diseases	$76.6M	Fidelity Investments, Jennison & 17 others	60/100
10th	Seres Therapeutics 2010, Cambridge (United States), Public	Developer of microbiome therapeutics to treat a wide range of diseases	$134M	Flagship Pioneering, Mayo Clinic Business Accelerator ... & 8 others	60/100
173rd	Toolbox Genomics 2016, San Francisco (United States), Seed	Provider of genome-based health insights to consumers	-	-	24/100